Linzess 290 MCG capsule UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJG4G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,229
Award facts
- Contract value 100% obligated
- $41,228.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $41,228.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count supplies of Linzess 290 micrograms capsules, with a completion date of January 7, 2026. This is a non-set-aside competitive award issued on January 6, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. Linzess is a prescription gastrointestinal medication used to treat chronic idiopathic constipation and irritable bowel syndrome, representing the type of specialized pharmaceutical commodity essential to military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc., operates this comprehensive global pharmaceutical support vehicle that supplies the full range of prescription medications, generic drugs, vaccines, and medical supplies needed across the Defense Health Agency and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains a significant position in the federal medical supply chain, competing on a full and open basis for such orders without set-aside protections.
Quick answers
Who was awarded contract SPE2DR26FJG4G?
SPE2DR26FJG4G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG4G worth?
The government has obligated $41,229 on SPE2DR26FJG4G.
Is contract SPE2DR26FJG4G an order under another contract?
Yes. SPE2DR26FJG4G is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG4G competed?
The extent of competition for SPE2DR26FJG4G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award